Decoding the 1st Medical Fee Revision – MEDIFAX web

News Highlights

MEDIFAX web’s explanatory article on the medical fee revision for fiscal year 2026. Medical institutions will require mid-to-long-term management and succession strategies that consider the revision cycle. Points raised include the “economies of scale” through group formation (maintaining facility standards, dispersing equipment investment burdens) and the utilization of tax schemes, including transitions to specific medical corporations and social medical corporations.

M&A Medical Editorial Department’s Perspective

The medical fee revision for fiscal year 2026 is not merely a change in points but demands a mid-to-long-term perspective for the management and succession strategies of medical institutions. In particular, “economies of scale” through group formation directly relates to meeting facility standards that are difficult to maintain individually and dispersing the burden of high-cost equipment investments. For example, by having multiple clinics in a region collaborate to introduce expensive medical equipment jointly or consolidate back-office functions (administration, accounting, HR), individual management efficiency can be dramatically improved. Furthermore, transitioning to a specific medical corporation or social medical corporation may allow for preferential tax treatment, leading to a reduction in tax burdens during business succession and securing funds for future business expansion. Amidst the changing business environment with each revision, early consideration of these strategic options is essential for building a sustainable healthcare delivery system.

Points Highlighted by This News

• The FY2026 revision compels medical institutions to formulate mid-to-long-term management and succession strategies.
• The “economies of scale” through group formation, for maintaining facility standards and dispersing equipment investment burdens, are increasing in importance.
• Utilizing tax schemes by transitioning to specific medical corporations and social medical corporations becomes an option for management and succession.
• The necessity for forward-looking management and succession plans, considering the revision cycle, is growing.

Practical Questions Arising from This News

• How will the current medical fee revision affect the maintenance of our clinic’s facility standards?
• What specific economies of scale can be expected from forming a group?
• Are there benefits to transitioning to a specific medical corporation or social medical corporation for a medical corporation of our clinic’s size?

If You Feel “Should I Consult Too?”

If you are concerned about your clinic’s management strategy or succession strategy in light of the FY2026 medical fee revision, it is worth considering consulting with an expert. It is particularly important to identify the optimal options for your clinic through concrete simulations regarding the potential utilization of advanced management and tax schemes, such as economies of scale through group formation and transitioning to a specific medical corporation or social medical corporation.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a completely success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here